Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Flapan

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
American Heart Journal|November 1, 1992
Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrationsA D Flapan, T R Shaw, C R Edwards, et al.
British Heart Journal|June 1, 1992
Percutaneous balloon dilatation of the mitral valve in patients who were unsuitable for surgical treatmentT R Shaw, D McAreavey, A R Essop, et al.
Journal of the American College of Cardiology|March 15, 1993
Differing patterns of cardiac parasympathetic activity and their evolution in selected patients with a first myocardial infarctionA D Flapan, R A Wright, J Nolan, et al.
Expert Review of Cardiovascular Therapy|January 3, 2014
Is myocardial ischemia really bad for you?Marc R Dweck, Iqbal Toor, Andrew D Flapan, et al.
International Journal of Cardiology|March 1, 1997
Effects of digoxin on time domain measures of heart rate variability in patients with stable chronic cardiac failure: withdrawal and comparison group studiesA D Flapan, N E Goodfield, R A Wright, et al.
Journal of the American College of Cardiology|July 1, 1994
Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarctionR A Wright, A D Flapan, K G Alberti, et al.
British Heart Journal|June 1, 1994
Cardiac parasympathetic activity in severe uncomplicated coronary artery diseaseJ Nolan, A D Flapan, J Reid, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failureA D Flapan, T R Shaw, C R Edwards, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The influence of posture on the response to loop diuretics in patients with chronic cardiac failure is reduced by angiotensin converting enzyme inhibitionA D Flapan, E Davies, C Waugh, et al.
International Journal of Cardiology|December 1, 1991
Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failureA D Flapan, E Davies, C Waugh, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
American Heart Journal|November 1, 1992
Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrationsA D Flapan, T R Shaw, C R Edwards, et al.
British Heart Journal|June 1, 1992
Percutaneous balloon dilatation of the mitral valve in patients who were unsuitable for surgical treatmentT R Shaw, D McAreavey, A R Essop, et al.
Journal of the American College of Cardiology|March 15, 1993
Differing patterns of cardiac parasympathetic activity and their evolution in selected patients with a first myocardial infarctionA D Flapan, R A Wright, J Nolan, et al.
Expert Review of Cardiovascular Therapy|January 3, 2014
Is myocardial ischemia really bad for you?Marc R Dweck, Iqbal Toor, Andrew D Flapan, et al.
International Journal of Cardiology|March 1, 1997
Effects of digoxin on time domain measures of heart rate variability in patients with stable chronic cardiac failure: withdrawal and comparison group studiesA D Flapan, N E Goodfield, R A Wright, et al.
Journal of the American College of Cardiology|July 1, 1994
Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarctionR A Wright, A D Flapan, K G Alberti, et al.
British Heart Journal|June 1, 1994
Cardiac parasympathetic activity in severe uncomplicated coronary artery diseaseJ Nolan, A D Flapan, J Reid, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failureA D Flapan, T R Shaw, C R Edwards, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The influence of posture on the response to loop diuretics in patients with chronic cardiac failure is reduced by angiotensin converting enzyme inhibitionA D Flapan, E Davies, C Waugh, et al.
International Journal of Cardiology|December 1, 1991
Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failureA D Flapan, E Davies, C Waugh, et al.
Pageof 9